GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D. Western Therapeutics Institute Inc (TSE:4576) » Definitions » Capital Expenditure

D. Western Therapeutics Institute (TSE:4576) Capital Expenditure : 円0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is D. Western Therapeutics Institute Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

D. Western Therapeutics Institute's cash flow for capital expenditures for the three months ended in Dec. 2024 was 円0.0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was 円0.00 Mil.

D. Western Therapeutics Institute Capital Expenditure Historical Data

The historical data trend for D. Western Therapeutics Institute's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D. Western Therapeutics Institute Capital Expenditure Chart

D. Western Therapeutics Institute Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.13 -2.90 -9.81 -14.94 -10.13

D. Western Therapeutics Institute Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

D. Western Therapeutics Institute Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D. Western Therapeutics Institute Inc (TSE:4576) » Definitions » Capital Expenditure
Comparable Companies
TSE:4598 TSE:130A TSE:4570 TSE:4591 TSE:4572 TSE:4594 TSE:4584 TSE:4891 TSE:4881 TSE:2385 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
Website
http://www.dwti.co.jp
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.

D. Western Therapeutics Institute Headlines

No Headlines